Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

4,110

Participants

Timeline

Start Date

May 31, 2002

Primary Completion Date

October 31, 2011

Study Completion Date

October 31, 2011

Conditions
Chronic Kidney DiseaseCardiovascular DiseaseDeath
Interventions
DRUG

High Dose Multivitamin

Vitamin B6 (Pyridoxine HCl): 50 mg Folic acid: 5.0 mg Vitamin B12: 1.0 mg Vitamin B1 (Thiamine HNO3): 1.5 mg Vitamin B2 (Riboflavin): 1.5 mg Vitamin C (Ascorbic Acid): 60 mg d-Biotin: 300 mcg Niacinamide: 20 mg Pantothenic Acid Calcium Pantothenate): 10 mg

DEVICE

Low Dose Multivitamin

Vitamin B6 (Pyridoxine HCl): 1.4 mg Folic acid: 0.0 mg Vitamin B12: 2.0 mcg Vitamin B1 (Thiamine HNO3): 1.5 mg Vitamin B2 (Riboflavin): 1.5 mg Vitamin C (Ascorbic Acid): 60 mg d-Biotin: 300 mcg Niacinamide: 20 mg Pantothenic Acid Calcium Pantothenate): 10 mg

Trial Locations (30)

11203

State University of New York Downstate Medical Center, Brooklyn

12208

Albany Medical Center, Albany

21201

University of Maryland Medical Center, Baltimore

27710

Duke University Medical Center, Durham

27834

East Carolina University, Greenville

35233

University of Alabama at Birmingham School of Medicine, Birmingham

46202

Indiana University, Indianapolis

52242

University of Iowa Hospitals and Clinics, Iowa City

53226

Medical College of Wisconsin, Milwaukee

53792

University of Wisconsin at Madison, Madison

55404

Hennepin County Medical Center, Minneapolis

55455

Faireview University Medical Center, Minneapolis

55905

Mayo Clinic, Rochester

60611

Northwestern University, Chicago

63110

Washington University, St Louis

90048

Cedars-Sinai Health System/Center for Kidney Diseases and Transplantation, Los Angeles

85004-1608

Banner Good Samaritan Transplant, Phoenix

90095-7306

University of California at Los Angeles, Los Angeles

94143-0780

University of California at San Francisco, San Francisco

62794-9638

Southern Illinois University, Springfield

04102

Maine Medical Center, Portland

02120

Brigham and Women's Hospital, Boston

48109-0364

University of Michigan Medical Center, Ann Arbor

43210-1228

The Ohio State University Medical Center, Columbus

97201-2940

Oregon Health Sciences University, Portland

19102-1192

Drexel University, Philadelphia

02903

Rhode Island Hospital, Providence

04023-900

Universidade Federal de Sao Paulo, São Paulo

N6A 5A5

London Health Sciences Center, London

M5G 2N2

Toronto General Hospital, Toronto

All Listed Sponsors
collaborator

Office of Dietary Supplements (ODS)

NIH

lead

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

NCT00064753 - Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT) | Biotech Hunter | Biotech Hunter